ACMT Position Statement: Safety Issues Regarding Prescription Fentanyl Products

Abstract

Fentanyl products must be prescribed with caution. Ou t p a t i e n t f e n t a n y l p ro du c t s , i n c l u d i n g transmucosal and transdermal (patch) forms, should only be prescribed to patients with uncontrolled chronic pain and opioid tolerance. ACMT supports the FDA’s decision to require a Risk Evaluation and Mitigation Strategy (REMS) for… (More)
DOI: 10.1007/s13181-016-0535-y

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics